Free Cholesterol Induces Higher Beta-Sheet Content in A Beta Peptide Oligomers by Aromatic Interaction with Phe19

Xiaolin Zhou,Jie Xu
DOI: https://doi.org/10.1371/journal.pone.0046245
IF: 3.7
2012-01-01
PLoS ONE
Abstract:Accumulating experimental evidence support an enhancing effect of free cholesterol on amyloid-beta (Ab) aggregation. To probe the mechanisms of cholesterol-mediated Ab aggregation, we applied all-atom molecular dynamic simulations on A beta 42 peptides in presence of free cholesterol. Several control systems were also designed to examine the specificity of cholesterol-residue interactions, including mutation on aromatic residue, substitution of cholesterol with sphingomyelin (SM) and DPPC bilayer, and a mixing SM and cholesterol. Each system was performed 4 independent simulations, with a total time of 560 ns. It was found that cholesterol increased beta-sheet formation by 4 folds, but the Phe19 -> Ser mutation on Ab42 peptide totally eliminated cholesterol's effect. A stable contact was recognized between the steroid group of cholesterol and the Benzyl group of Phe19. Interestingly, our simulation revealed a regular 1 ns time interval between the establishment of cholesterol-phenylalanine contact and consequent beta-sheet formation, suggesting an important role of steroid-benzyl interaction in cholesterol-mediated aggregation. The presence of SM slightly increased beta-sheet formation, but the mixture of cholesterol and SM had a strong induction effect. Also, the measurement of Phe19-lipid distance indicates that aromatic side chains of peptides prone to bind to cholesterol on the surface of the mixed micelle. In the DPPC system, polar chains were attracted to the surface of membrane, yielding moderate increase of beta-sheet formation. These results shed light on the mechanism of cholesterol-mediated fibrillogenesis, and help to differentiate the effects of cholesterol and other lipids on beta-sheet formation process.
What problem does this paper attempt to address?